Financhill
Back

Alcon Quote, Financials, Valuation and Earnings

Alcon Price Quote

$84.78
+0.02 (+0.71%)
(Updated: December 21, 2024 at 5:14 AM ET)

Alcon Key Stats

Sell
41
Alcon (ALC) is a Sell

Day range:
$84.06 - $85.33
52-week range:
$74.30 - $101.10
Dividend yield:
0.31%
P/E ratio:
43.24
P/S ratio:
4.32
P/B ratio:
2%

Volume:
917.6K
Avg. volume:
1.1M
1-year change:
13.41%
Market cap:
$41.9B
Revenue:
$9.5B
EPS:
$2.34

How Much Does Alcon Make?

Data Unavailable

Is Alcon Growing As A Company?

Data Unavailable

Alcon Stock Price Performance

  • Did Alcon Stock Go Up Last Month?
    Alcon share price went down by -0.87% last month
  • Did ALC's Share Price Rise Over The Last Year?
    ALC share price rose by 13.41% over the past 1 year

What Is Alcon 52-Week High & Low?

  • What Is Alcon’s 52-Week High Share Price?
    Alcon has traded as high as $101.10 over the past 52 weeks
  • What Is Alcon’s 52-Week Low Share Price?
    Alcon has traded as low as $74.30 over the past 52 weeks

Alcon Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alcon?

Data Unavailable

Is Alcon Cash Flow Positive?

Data Unavailable

Alcon Return On Invested Capital

Data Unavailable

Alcon Earnings Date & Stock Price

  • What Is Alcon's Stock Price Today?
    A single share of ALC can be purchased today for 84.76
  • What Is Alcon’s Stock Symbol?
    Alcon trades on the nyse under the ticker symbol: ALC
  • When Is Alcon’s Next Earnings Date?
    The next quarterly earnings date for Alcon is scheduled on February 28, 2025
  • When Is ALC's next ex-dividend date?
    Alcon's next ex-dividend date is May 14, 2024
  • How To Buy Alcon Stock?
    You can buy Alcon shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Alcon Competitors

  • Who Are Alcon's Competitors?
    Below is a list of companies who compete with Alcon or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • NLS Pharmaceutics Ltd (NLSP)
    • Novartis AG (NVS)

Alcon Dividend Yield

Data Unavailable

Alcon Analyst Estimates

YoY Growth Past Surprise
EPS: 29.27% 8.79%
Revenue: 5.37% -0.66%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 100.10
Upside from Last Price: 18.1%

Major Shareholders

Data Unavailable